Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans.

Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, Nathan PJ, Pike VW, Innis RB.

J Nucl Med. 2006 Jan;47(1):100-4.

2.

1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.

Virta JR, Tolvanen T, Någren K, Brück A, Roivainen A, Rinne JO.

J Nucl Med. 2008 Mar;49(3):347-53. doi: 10.2967/jnumed.107.047233. Epub 2008 Feb 20.

3.

Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.

Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB.

J Nucl Med. 2004 Sep;45(9):1555-9.

4.

Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans.

Garg PK, Lokitz SJ, Nazih R, Garg S.

J Nucl Med. 2017 Mar;58(3):473-478. doi: 10.2967/jnumed.116.180059. Epub 2016 Sep 22.

PMID:
27660145
5.

Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.

Obrzut SL, Koren AO, Mandelkern MA, Brody AL, Hoh CK, London ED.

Nucl Med Biol. 2005 Nov;32(8):869-74.

6.

Human biodistribution and radiation dosimetry of the tachykinin NK1 antagonist radioligand [18F]SPA-RQ: comparison of thin-slice, bisected, and 2-dimensional planar image analysis.

Sprague DR, Chin FT, Liow JS, Fujita M, Burns HD, Hargreaves R, Stubbs JB, Pike VW, Innis RB, Mozley PD.

J Nucl Med. 2007 Jan;48(1):100-7.

7.

Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates.

Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, Pike VW, Innis RB.

Nucl Med Commun. 2004 Jul;25(7):737-42.

8.

Human radiation dose estimation of (11)C-CFT using whole-body PET.

Huang T, Wang H, Tang G, Liang X, Deng H, Yi C, Zhang X.

Clin Nucl Med. 2012 Dec;37(12):1159-62. doi: 10.1097/RLU.0b013e318266cd1b.

PMID:
23154473
9.

Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Laymon CM, Narendran R, Mason NS, Carney JP, Lopresti BJ, Mathis CA, Mountz JM, Sashin D, Frankle WG.

Mol Imaging Biol. 2012 Feb;14(1):115-22. doi: 10.1007/s11307-011-0478-2.

PMID:
21365327
10.

Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.

Slifstein M, Hwang DR, Martinez D, Ekelund J, Huang Y, Hackett E, Abi-Dargham A, Laruelle M.

J Nucl Med. 2006 Feb;47(2):313-9.

11.

Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.

Herzog H, Elmenhorst D, Winz O, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x. Epub 2008 Mar 29.

PMID:
18373090
12.

Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.

Takano A, Halldin C, Varrone A, Karlsson P, Sjöholm N, Stubbs JB, Schou M, Airaksinen AJ, Tauscher J, Gulyás B.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):630-6. Epub 2007 Nov 14.

PMID:
18000665
13.

Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates.

Seneca N, Andree B, Sjoholm N, Schou M, Pauli S, Mozley PD, Stubbs JB, Liow JS, Sovago J, Gulyás B, Innis R, Halldin C.

Nucl Med Commun. 2005 Aug;26(8):695-700.

PMID:
16000987
14.

Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates.

Tipre DN, Lu JQ, Fujita M, Ichise M, Vines D, Innis RB.

Nucl Med Commun. 2004 Jan;25(1):81-6.

PMID:
15061269
15.

Biodistribution and radiation dosimetry of [11C]raclopride in healthy volunteers.

Ribeiro MJ, Ricard M, Bourgeois S, Lièvre MA, Bottlaender M, Gervais P, Dollé F, Syrota A.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):952-8. Epub 2005 Apr 20.

PMID:
15841376
16.

Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET.

Bullich S, Slifstein M, Passchier J, Murthy NV, Kegeles LS, Kim JH, Xu X, Gunn RN, Herance R, Gispert JD, Gutiérrez A, Farré M, Laruelle M, Catafau AM.

Mol Imaging Biol. 2011 Aug;13(4):776-84. doi: 10.1007/s11307-010-0398-6.

PMID:
20730499
17.

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans.

Liu N, Li M, Li X, Meng X, Yang G, Zhao S, Yang Y, Ma L, Fu Z, Yu J.

J Nucl Med. 2009 Feb;50(2):303-8. doi: 10.2967/jnumed.108.056556. Epub 2009 Jan 21.

18.

Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.

Scheinin NM, Tolvanen TK, Wilson IA, Arponen EM, Någren KA, Rinne JO.

J Nucl Med. 2007 Jan;48(1):128-33.

19.

In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390.

Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN, Hwang Y, Hwang DR, Abi-Dargham A, Laruelle M.

Mol Imaging Biol. 2007 May-Jun;9(3):117-25.

PMID:
17473957
20.

Radiation dose estimates in humans for (11)C-acetate whole-body PET.

Seltzer MA, Jahan SA, Sparks R, Stout DB, Satyamurthy N, Dahlbom M, Phelps ME, Barrio JR.

J Nucl Med. 2004 Jul;45(7):1233-6.

Supplemental Content

Support Center